AI

Dr. Ali Parsa, CEO and founder of Babylon, made the announcement at an event organized this week at Babylon's headquarters in London.

Swarm AI, a network of human practitioners whose collective diagnoses decisions were moderated by an AI, offers another approach to AI-based medical image analysis. 

The KardiaK Software Platform could be used with mobile ECG devices to identify potential cases of kidney disease.

Both companies focus on engaging patients through health apps, and analyzing their collected data for insights using AI. 

CHC Program Chair Dr. Joseph Kvedar says the event will focus on technology coming in the next 18 to 24 months.

Clarify's software platform includes consumer engagement apps, patient management tools, and a value-based performance insight generator.

Notable announced its Series A funding round led by F-Prime Capital Partners and Oak HC/FT to further develop its wearable AI voice assistant for doctors. 

Santa Monica-based Headspace announced that it would be acquiring voice-enabled AI system Alpine.Ai for an undisclosed sum this morning. 

Pivotal trial data that led to April’s de novo clearance of the first AI-based diagnostic system to not require clinician interpretation is now available to the public.

ReMix, a new technology in the works at MIT's Computer Science and Artificial Intelligence Laboratory, seeks to make progress toward a new paradigm of treatment – one that's less reliant on endoscopy and surgery, but instead relies on sensors and what scientists call an "in-body GPS" to help make diagnoses and guide drug administration.